Webinars

The IPS runs webinars throughout the year.

Join IPS for instant access to all past webinars.

• Manufacturing trends for CAR-T cell therapies (Douglas Miller) 2019
• Pharmacy in 2050. Forces That Will Shape Practice (Sola Solarin) 2017
• Sustainable Antibiotics; Antimicrobial Resistance (AMR). Pharmaceutical Industry Perspectives (Lucas Jan Wiarda) 2017
• Pharmacutical Patents (Joanna Brougher) 2017
• Data integrity (Michael Anisfeld) 2016
• The future of the industrial pharmaceutical profession (EFPIA) 2016
• Good distribution practice audits (Petra Lehtinen, Finland) 2015
• Pharmacovigilance audit II on common findings (Susanna Heinonen, Finland) 2015
• Pharmacovigilance audits I (Susanna Heinonen, Finland) 2015
• Current issues in biotechnology (Igor Linhares de Castro, Brazil) 2014
• Fundamentals and essentials of validation (Michael Anisfeld, USA) 2014
• Current developments in drug reg​ulation (Alan Chalmers, Switzerland) 2014
• Antibody drug conjugates (Matthew Cherian, USA) 2013
• Good distribution practices — Securing the supply chain (Michael Anisfeld, USA) 2013
• Supplier qualification goes beyond regulatory compliance (Wolfgang Löscher Filho, Brazil) 2013
• Passing a national regulatory inspection (Michael Anisfeld, USA) 2013

At the FIP congress

IPS activities at the 2017 FIP World Congress of Pharmacy and Pharmaceutical Sciences in Seoul, South Korea, included:

• Biosimilars for all: Research, regulation and responsible use (session)
• Individualized medicines: An ethical approach (session)
• Gene-based therapy (session)
• Supporting patients with chronic diseases (session)
• Counterfeit medicines: Safeguarding the supply chain, protecting people (session)
• Antimicrobial stewardship – Looking for global solutions (session)
• Shortages: The International Toronto Summit and beyond? (session)
• Short Oral Presentations
• Industry site visits
• Students half day
• IPS business meeting (membership assembly)
• IPS dinner
• Good Manufacturing Practices seminar

Topics organised by the IPS for recent FIP congresses (2014, 2015, 2016) include:

• Novel regulatory approaches to accelerate access to medicines
• Can pharmacists contribute to improving patient adherence as part of pharmacovigilance?
• Improving outcomes through novel technologies – Let’s innovate together!
• Biosimilars: Understanding the issues
• Student careers
• Industrial insights — potential careers in industrial pharmacy
• Good manufacturing practice seminar
• Compounding – A core competence for the pharmacist
• Medicines for all - Impediments to achieving the goal
• Transparency and social media - Empowering the pharmacist
• Lost in translation - Preserving scientific knowledge across languages
• Do patents limit access to new medicines?
• Is there a need to harmonise the training of industrial pharmacists?
• Insights into biosimilars and non-biological complex drugs
• Improving the quality of the information pharmacist provided to patients.
• Age-related medicines
• From development to marketing

FIP members have access to these presentations online. 

Other events

• Symposium on New Frontiers in Manufacturing Technology, Regulatory Sciences and Pharmaceutical Quality System (SINDUSFARMA / ANVISA / FIP-IPS), held annually in Brazil in June each year.

Industrial Pharmacy journal

Published quarterly in association with Euromed Communications, this journal is produced for pharmaceutical scientists and executives working in or liaising with industry.

Annual report

The IPS annual report is available here.